Alcohol Use Disorders
Global mortality data, country rankings, and trends for Alcohol Use Disorders from 1990 to 2021.
| # | Country | Share (%) | Region |
|---|
Alcohol Use Disorders is a significant contributor to the global burden of disease. This page presents data from the Institute for Health Metrics and Evaluation (IHME) Global Burden of Disease Study, showing mortality trends, country rankings, and regional patterns. Understanding the epidemiology of alcohol use disorders helps inform public health interventions and resource allocation.
This data is sourced from the Institute for Health Metrics and Evaluation (IHME) Global Burden of Disease Study 2023, processed via Our World in Data. Values represent each cause's share of total deaths (%) unless otherwise noted. Explore related mortality data using the links below.
Alcohol use disorders directly cause approximately 170,000 deaths per year and contribute to a far larger toll through liver cirrhosis, cardiovascular disease, cancer, road injuries, and violence — totalling an estimated 3 million alcohol-attributable deaths annually (5.3% of all deaths). Harmful alcohol use is a leading risk factor for premature mortality among 15-49 year-olds. Eastern Europe and Central Asia have the highest per-capita alcohol consumption and alcohol-attributable death rates globally, driven by heavy episodic drinking patterns. The relationship between alcohol and mortality is complex: moderate consumption has been claimed to confer cardiovascular benefit, but recent large-scale studies suggest no safe level of consumption when all health outcomes are considered. Alcohol use disorders disproportionately affect men, with a male-to-female mortality ratio of roughly 3:1. Economic costs from alcohol harm — including healthcare, lost productivity, and criminal justice — exceed 1% of GDP in most countries.
Across 209 countries, alcohol use disorders accounts for an average of 0.4% of total deaths. Regional disparities are substantial: Latin America & Caribbean has the highest regional average at 0.6%, while Middle East, North Africa, Afghanistan & Pakistan records the lowest at 0.1% — a 9.9-fold difference that underscores the geographic inequality in alcohol use disorders mortality burden.
The WHO SAFER initiative outlines five high-impact strategies: Strengthen restrictions on alcohol availability, Advance and enforce drink-driving countermeasures, Facilitate access to screening and brief interventions, Enforce bans or comprehensive restrictions on alcohol advertising, and Raise prices on alcohol through excise taxes. Minimum unit pricing, reduced outlet density, and restrictions on serving hours are all evidence-based population measures. Clinical management includes pharmacotherapy (naltrexone, acamprosate), psychosocial interventions, and mutual-help groups.